Search
for

    Sort by

    Research 30 of 1000+

    1. Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events PLoS ONE · 2025 · 2 citations
    2. Safety assessment of <i>Linum usitatissimum</i> (Linn.) Ingestion in New Zealand rabbits African Journal of Traditional Complementary and Alternative Medicines · 2016 · 2 citations
    3. Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study The Journal of Dermatology · 2025
    4. Safety Profile and Efficacy of Biosea® Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation Cosmetics · 2025
    5. 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    6. Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial The World Journal of Men s Health · 2023 · 5 citations
    7. An Assessment of the Safety, Efficacy, and Tolerability of a Novel Scalp Treatment Regimen Combining a Hydroxy Acid-Based Scrub and Copper Tripeptide Serum in the Management of Seborrheic Dermatitis in Adults Cureus · 2024 · 4 citations
    8. Assessment of efficacy and safety of dapsone gel 5% in the treatment of acne vulgaris مجله كليه طب الكندي · 2019 · 1 citations
    9. Assessment of Efficacy and Safety Profile of Platelet Rich Plasma (PRP) Therapy with Derma Roller in the Treatment of Female Pattern Hair Loss International journal of science and research · 2023
    10. Assessment of Efficacy and Safety Profile of Platelet Rich Plasma (PRP) Therapy with Dermaroller in the Treatment of Female Pattern Hair Loss 2020
    11. 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2024 · 2 citations
    12. Hair growth efficacy and safety assessment of an ayurvedic leave-on treatment: a clinical trial International Journal of Research in Dermatology · 2025
    13. Assessment of the efficacy and safety of Indulekha svetakutaja hair oil in management of dandruff: a randomized, double-blind, and placebo-controlled study International Journal of Research in Dermatology · 2024
    14. Final Report on the Safety Assessment of Hypericum Perforatum Extract and Hypericum Perforatum Oil International journal of toxicology · 2001 · 23 citations
    15. Final Report on the Safety Assessment of Human Placental Protein, Hydrolyzed Human Placental Protein, Human Placental Enzymes, Human Placental Lipids, Human Umbilical Extract, Placental Protein, Hydrolyzed Placental Protein, Placental Enzymes, Placental Lipids, and Umbilical Extract International Journal of Toxicology · 2002 · 13 citations
    16. Restoring natural hair pigmentation: clinical assessment of safety and efficacy of an ayurvedic leave-on treatment International Journal of Research in Dermatology · 2025
    17. Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite Regulatory toxicology and pharmacology · 2017 · 3 citations
    18. First-in-Human Study to Investigate the Safety Assessment of Peri-Implant Soft Tissue Regeneration with Micronized-Gingival Connective Tissue: A Pilot Case Series Study Medicines · 2023
    19. Fractional microneedle radiofrequency - mechanism of action and assessment of safety, effectiveness in the treatment, and possible side effects based on a review of scientific literature Journal of Education, Health and Sport · 2023
    20. Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study Drugs - Real World Outcomes · 2019 · 8 citations
    21. JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment Mendeley Data · 2025
    22. JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment Mendeley Data · 2025
    23. The mechanism of action of platelet-rich plasma – composition analysis and safety assessment Current Issues in Pharmacy and Medical Sciences · 2021
    24. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride Journal of Dermatological Treatment · 2013 · 66 citations
    25. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment Dermatology and therapy · 2020 · 24 citations
    26. One‐Year Follow‐Up of Acne Vulgaris Patients Treated With Nonablative Monopolar Radiofrequency: Efficacy and Safety Assessment Lasers in Surgery and Medicine · 2025
    27. QbD-Enabled Development of Quercetin Dihydrate-Loaded Nanostructured Lipid Carriers: In vitro Characterization, Safety and Efficacy Assessment in Androgenetic Alopecia Mice Model BioNanoScience · 2025
    28. Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss Journal of Investigative Dermatology Symposium Proceedings · 2013 · 17 citations
    29. Scale-Up of a Medicinal and Aromatic Plant-Based Shampoo Formulation: Physicochemical Quality, Microbiological Safety, and Stability Analyses Journal of Apitherapy and Nature · 2026
    30. Scale-Up of a Medicinal and Aromatic Plant-Based Shampoo Formulation: Physicochemical Quality, Microbiological Safety, and Stability Analyses DergiPark (Istanbul University) · 2026